D L Parkes - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

D L Parkes

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Journal of Clinical Microbiology|April 1, 1991

Seroreactive recombinant herpes simplex virus type 2-specific glycoprotein GD L Parkes, C M Smith, J M Rose, et al.

Biochemical and Biophysical Research Communications|June 26, 1995

Construction of a chimeric antibody with therapeutic potential for cancers which overexpress c-erbB-2H L Liu, D L Parkes, B C Langton, et al.

Journal of Clinical Microbiology|June 1, 1990

Serological evaluation of Escherichia coli-expressed human T-cell leukemia virus type I env, gag p24, and tax proteinsS R Coates, A J Harris, D L Parkes, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Journal of Clinical Microbiology|April 1, 1991

Seroreactive recombinant herpes simplex virus type 2-specific glycoprotein GD L Parkes, C M Smith, J M Rose, et al.

Biochemical and Biophysical Research Communications|June 26, 1995

Construction of a chimeric antibody with therapeutic potential for cancers which overexpress c-erbB-2H L Liu, D L Parkes, B C Langton, et al.

Journal of Clinical Microbiology|June 1, 1990

Serological evaluation of Escherichia coli-expressed human T-cell leukemia virus type I env, gag p24, and tax proteinsS R Coates, A J Harris, D L Parkes, et al.

Pageof 1